BORTEZOMIB vs VELCADE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Attribute	BORTEZOMIB	VELCADE
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BORTEZOMIB	BORTEZOMIB
Manufacturer	Accord Hlthcare	Takeda Pharms USA
Dosage forms	Injectable, Powder	Injectable
Drug class	Proteasome Inhibitor	Proteasome Inhibitor
Boxed warning	None	None
Treats	Multiple Myeloma, Mantle-Cell Lymphoma	Multiple Myeloma, Mantle-Cell Lymphoma

bortezomib velcade

Rating

New

Pharmacy pays

—

Type

Active ingredient

BORTEZOMIB

Manufacturer

Accord Hlthcare

Takeda Pharms USA

Dosage forms

Injectable, Powder

Injectable

Drug class

Proteasome Inhibitor

Boxed warning

None

Treats

Multiple Myeloma, Mantle-Cell Lymphoma

Frequently asked questions

What is the difference between Bortezomib and Velcade?

Both Bortezomib and Velcade share the active ingredient Bortezomib.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.